VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 41 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $25,704 | +78.9% | 25,200 | 0.0% | 0.00% | +50.0% |
| Q4 2023 | $14,364 | -30.9% | 25,200 | +26.0% | 0.00% | -33.3% |
| Q3 2023 | $20,800 | +44.6% | 20,000 | +96.0% | 0.00% | +50.0% |
| Q2 2023 | $14,389 | -11.3% | 10,205 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $16,226 | +8.9% | 10,205 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $14,900 | – | 10,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,094,174 | $24,815,000 | 0.97% |
| Samsara BioCapital, LLC | 711,039 | $5,703,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 729,509 | $5,851,000 | 0.75% |
| Aisling Capital Management LP | 288,571 | $2,314,000 | 0.46% |
| Opaleye Management Inc. | 258,556 | $2,074,000 | 0.39% |
| AlphaCentric Advisors LLC | 92,402 | $741,000 | 0.19% |
| HAMILTON LANE ADVISORS LLC | 71,491 | $573,000 | 0.10% |
| Jasper Ridge Partners, L.P. | 92,939 | $745,000 | 0.03% |
| BOURGEON CAPITAL MANAGEMENT LLC | 18,750 | $150,000 | 0.03% |
| Palo Alto Investors LP | 33,212 | $266,000 | 0.02% |